113 related articles for article (PubMed ID: 24463003)
1. Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? In the search for minimizing of the adverse effects of PAMAM administration.
Labieniec-Watala M; Przygodzki T; Sebekova K; Watala C
Int J Pharm; 2014 Apr; 464(1-2):152-67. PubMed ID: 24463003
[TBL] [Abstract][Full Text] [Related]
2. Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats.
Karolczak K; Rozalska S; Wieczorek M; Labieniec-Watala M; Watala C
Int J Pharm; 2012 Oct; 436(1-2):508-18. PubMed ID: 22721855
[TBL] [Abstract][Full Text] [Related]
3. Effect of poly(amido)amine (PAMAM) G4 dendrimer on heart and liver mitochondria in an animal model of diabetes.
Labieniec M; Ulicna O; Vancova O; Kucharska J; Gabryelak T; Watala C
Cell Biol Int; 2009 Dec; 34(1):89-97. PubMed ID: 19947941
[TBL] [Abstract][Full Text] [Related]
4. PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats.
Labieniec M; Ulicna O; Vancova O; Glowacki R; Sebekova K; Bald E; Gabryelak T; Watala C
Int J Pharm; 2008 Nov; 364(1):142-9. PubMed ID: 18761397
[TBL] [Abstract][Full Text] [Related]
5. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
6. Use of poly(amido)amine dendrimers in prevention of early non-enzymatic modifications of biomacromolecules.
Labieniec M; Watala C
Biochimie; 2010 Oct; 92(10):1296-305. PubMed ID: 20542077
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of the biomedical effectiveness of poly(amido)amine dendrimers generation 4.0 as a drug and as drug carriers: a systematic review and meta-analysis.
Jędrych M; Borowska K; Galus R; Jodłowska-Jędrych B
Int J Pharm; 2014 Feb; 462(1-2):38-43. PubMed ID: 24374222
[TBL] [Abstract][Full Text] [Related]
8. The Janus face of PAMAM dendrimers used to potentially cure nonenzymatic modifications of biomacromolecules in metabolic disorders-a critical review of the pros and cons.
Labieniec-Watala M; Karolczak K; Siewiera K; Watala C
Molecules; 2013 Nov; 18(11):13769-811. PubMed ID: 24213655
[TBL] [Abstract][Full Text] [Related]
9. How do the full-generation poly(amido)amine (PAMAM) dendrimers activate blood platelets? Activation of circulating platelets and formation of "fibrinogen aggregates" in the presence of polycations.
Watala C; Karolczak K; Kassassir H; Talar M; Przygodzki T; Maczynska K; Labieniec-Watala M
Int J Pharm; 2016 Apr; 503(1-2):247-61. PubMed ID: 26319628
[TBL] [Abstract][Full Text] [Related]
10. PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex.
Jiang YY; Tang GT; Zhang LH; Kong SY; Zhu SJ; Pei YY
J Drug Target; 2010 Jun; 18(5):389-403. PubMed ID: 20055559
[TBL] [Abstract][Full Text] [Related]
11. Ambiguous effect of dendrimer PAMAM G3 on rat heart respiration in a model of an experimental diabetes - Objective causes of laboratory misfortune or unpredictable G3 activity?
Siewiera K; Labieniec-Watala M
Int J Pharm; 2012 Jul; 430(1-2):258-65. PubMed ID: 22486957
[TBL] [Abstract][Full Text] [Related]
12. Poly(amido amine) dendrimers in oral delivery.
Yellepeddi VK; Ghandehari H
Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2.5 and G3.5--in vitro and in vivo study.
Borowska K; Wołowiec S; Głowniak K; Sieniawska E; Radej S
Int J Pharm; 2012 Oct; 436(1-2):764-70. PubMed ID: 22884834
[TBL] [Abstract][Full Text] [Related]
15. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
16. Complexes of dendrimers with bovine serum albumin.
Mandeville JS; Tajmir-Riahi HA
Biomacromolecules; 2010 Feb; 11(2):465-72. PubMed ID: 20085247
[TBL] [Abstract][Full Text] [Related]
17. Probing the binding of cationic lipids with dendrimers.
Mandeville JS; Bourassa P; Tajmir-Riahi HA
Biomacromolecules; 2013 Jan; 14(1):142-52. PubMed ID: 23130659
[TBL] [Abstract][Full Text] [Related]
18. Visual observation and characterization of fluorescent poly(amido amine) dendrimer in film state.
Saravanan G; Imae T
J Nanosci Nanotechnol; 2011 Jun; 11(6):4838-45. PubMed ID: 21770112
[TBL] [Abstract][Full Text] [Related]
19. In silico search, chemical characterization and immunogenic evaluation of amino-terminated G4-PAMAM-HIV peptide complexes using three-dimensional models of the HIV-1 gp120 protein.
Rodríguez-Fonseca RA; Bello M; de Los Muñoz-Fernández MÁ; Luis Jiménez J; Rojas-Hernández S; Fragoso-Vázquez MJ; Gutiérrez-Sánchez M; Rodrigues J; Cayetano-Castro N; Borja-Urby R; Rodríguez-Cortés O; García-Machorro J; Correa-Basurto J
Colloids Surf B Biointerfaces; 2019 May; 177():77-93. PubMed ID: 30711762
[TBL] [Abstract][Full Text] [Related]
20. Chronic intraperitoneal insulin delivery, as compared with subcutaneous delivery, improves hepatic glucose metabolism in streptozotocin diabetic rats.
Mason TM; Gupta N; Goh T; El-Bahrani B; Zannis J; van de Werve G; Giacca A
Metabolism; 2000 Nov; 49(11):1411-6. PubMed ID: 11092503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
